MHC Class II alleles in ulcerative colitis-associated colorectal cancer
MHC Class II alleles in ulcerative colitis-associated colorectal cancer
复制标题
DOI:
10.1136/gut.2008.166686
复制
发表时间:
2009-09-01
期刊:
影响因子:
24.5
通讯作者:
Smyrk, T. C.
中科院分区:
文献类型:
--
作者:
Garrity-Park, M. M.;Loftus, E. V., Jr.;Smyrk, T. C.
Objectives: Patients with ulcerative colitis are at risk for colorectal cancer (CRC). Although prior studies have shown a link between HLA genotypes and ulcerative colitis (UC) susceptibility, none have investigated HLA genotypes and UC-CRC. We therefore investigated HLA-DR/DQ alleles in UC-CRC cases and UC-controls. Furthermore, since methylation of the Class II transactivator (CIITA) gene may silence HLA expression in tumours, we correlated HLA allele frequencies with CIITA gene methylation and HLA-DR expression.Methods: Cases and controls were matched for duration/extent of ulcerative colitis, age, ethnicity and gender, but not for primary sclerosing cholangitis (PSC). DNA was extracted from archived tissue blocks from 114 UC-CRC cases and 114 UC-controls. HLA-DR/DQ genotyping was performed using sequence-specific-oligonucleotide polymerase chain reaction (SSO-PCR). CIITA methylation was determined using methylation-specific PCR. HLA-DR immunohistochemistry was done following standard protocols.Results: UC-CRC cases were more likely than UC-controls to carry the DR17 or DR13 alleles (p